Experienced in Metastatic Pleural Tumor

Ozgur Batum

University Of Health Sciences Dr. Suat Seren Chest Diseases Hospital
Izmir, TR 
Experienced in Metastatic Pleural Tumor
University Of Health Sciences Dr. Suat Seren Chest Diseases Hospital
Izmir, TR 
OverviewLocationsClinical Research

Overview

Ozgur Batum practices in Izmir, Turkey. Batum is rated as an Experienced expert by MediFind in the treatment of Metastatic Pleural Tumor. Their top areas of expertise are Metastatic Pleural Tumor, Severe Acute Respiratory Syndrome (SARS), Pneumonia, and COVID-19.

Their clinical research consists of co-authoring 21 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Metastatic Pleural Tumor.

Locations

University of Health Sciences Dr. Suat Seren Chest Diseases Hospital
Izmir, Turkey

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Trial For Evaluation of Efficacy and Safety of SARS-CoV-2 Vaccine (Vero Cell), Inactivated
Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Trial For Evaluation of Efficacy and Safety of SARS-CoV-2 Vaccine (Vero Cell), Inactivated
Enrollment Status: Completed
Publish Date: May 24, 2024
Intervention Type: Biological
Study Drug: CoronaVac Vaccine
Study Phase: Phase 3
Open Label, Multi-Center Phase 3 Clinical Trial to Determine Safety, Efficacy, and Immunogenicity of Booster Vaccination Against SARS-CoV-2
Open Label, Multi-Center Phase 3 Clinical Trial to Determine Safety, Efficacy, and Immunogenicity of Booster Vaccination Against SARS-CoV-2
Enrollment Status: Completed
Publish Date: February 29, 2024
Intervention Type: Biological
Study Phase: Phase 3
Efficacy, Immunogenicity, and Safety of the Two-Dose Inactivated COVID-19 Vaccine (TURKOVAC) Versus the Two-Dose CoronaVac (Sinovac) Vaccine in Healthy Subjects: A Randomized, Observer-Blinded, Phase III Clinical Trial
Efficacy, Immunogenicity, and Safety of the Two-Dose Inactivated COVID-19 Vaccine (TURKOVAC) Versus the Two-Dose CoronaVac (Sinovac) Vaccine in Healthy Subjects: A Randomized, Observer-Blinded, Phase III Clinical Trial
Enrollment Status: Completed
Publish Date: February 29, 2024
Intervention Type: Biological
Study Phase: Phase 3
View 2 Less Clinical Trials

21 Total Publications

The association of metabolic positron emission tomography/computed tomography parameters with survival in small cell lung cancer.
The association of metabolic positron emission tomography/computed tomography parameters with survival in small cell lung cancer.
Journal: Annals of Saudi medicine
Published: February 10, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Batum's expertise for a condition
ConditionClose
        View All 11 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile